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ABSTRACT 
Here we present a strategy for the fabrication of biomimetic nanoarrays, based on the use of DNA 
origami, that permit the multivalent investigation of ligand-receptor molecule interactions in 
cancer cell spreading, with nanoscale spatial resolution and single-molecule control. We employed 
DNA-origami to control the nanoscale spatial organization of integrin- and epidermal growth 
factor (EGF)- binding ligands that modulate epidermal cancer cell behaviour. By organizing these 
multivalent DNA nanostructures in nanoarray configurations on nanopatterned surfaces, we 
demonstrated the cooperative behaviour of integrin- and EGF- ligands in the spreading of human 
cutaneous melanoma cells: this cooperation was shown to depend on both the number and ratio of 
the selective ligands employed. Notably, the multivalent biochips we have developed allowed for 
this cooperative effect to be demonstrated with single-molecule control and nanoscale spatial 
resolution. By and large, the platform presented here is of general applicability for the study, with 
molecular control, of different multivalent interactions governing biological processes, from the 
function of cell-surface receptors, to protein-ligand binding and pathogen inhibition. 
  
Cells interact with the extracellular matrix (ECM) via transmembrane proteins called integrins: 
integrin-mediated interactions with the ECM control cell adhesion, migration and invasion,1, 2 and 
play a central role in cancer.3 Notably, integrins work in concert with other membrane receptors to 
modulate normal and cancer cell behaviour,4-6 but the combined spatial organization and 
stoichiometry required are not known. Studying these relationships at the nanoscale is a significant 
challenge as current strategies do not allow for combined multivalence capability and nanoscale 
spatial control; this in turn represents a barrier to our understanding of the fundamental 
mechanisms by which receptor crosstalk dictates cell behaviour, including metastasis.  
Various approaches have been pursued to control the spatial organization of cellular adhesion 
receptors on surfaces7-13 in order to understand the ECM geometries that affect cell spreading and 
focal contact formation,14-17 and to develop functional integrin complexes.18,19 Among these works, 
the most notable in terms of single-integrin control, as well as nanoscale spatial resolution, are 
based on the use of metal nanodots employed as anchoring points for cell-binding peptides, and 
the consequent fabrication of ECM biomimetic nanoarrays.12,13,20-23 In this context, micellar diblock 
copolymer self-assembly demonstrated that a preferential spacing of ~60nm between integrin 
binding sites is key for efficient cell spreading and viability;10,24 this approach further allowed 
investigating optimal substrate rigidity for adhesion formation as a function of ligand spacing.8 
Additionally, a nanolithographic strategy was employed to fabricate nanoscale bio-arrays that 
showed the importance of integrin clustering: the juxtaposition within 60 nm of at least 4 cell-
adhesion peptide-liganded integrins was shown to be required for the establishment of stable focal 
adhesions.11 A similar approach was used to further employ this platform in bifunctional 
configurations.25 However, while these approaches shed light on the importance of the nanoscale 
geometrical arrangement of integrin-binding peptides in ECM-mimicking substrates, they do not 
allow for combined multivalence capability and nanoscale spatial resolution toward the targeting 
of different, and synergistic, cell receptors with single-molecule control. 
Here we report a strategy for the fabrication of biomimetic nanoarrays that permit the 
investigation of multivalent ligand-receptor molecule interactions in cell spreading, with nanoscale 
spatial resolution and single-molecule control. In particular, we combined the ability of DNA-
origami to control the nanoscale spatial organization26-32 of distinct cell-binding ligands, with our 
recently developed Focused Ion Beam (FIB) patterning procedure to assemble functional DNA 
nanostructures on surfaces in array configurations.33 This allowed us to fabricate reusable 
biomimetic substrates and, as a proof of concept, study integrin-dependent responses and their 
cooperation with epidermal growth factor (EGF)34-36 that modulate epidermal cancer cell behaviour. 
A cooperative behaviour in the spreading of human cutaneous melanoma cells was demonstrated 
when both integrin- and EGF-binding ligands were assembled in the biomimetic nanoarrays. 
Additionally, this cooperation was shown to depend on both the number and ratio of the selective 
ligands employed and assembled with nanoscale spatial control. 
 
RESULTS AND DISCUSSION 
We engineered triangular DNA origami nanostructures with both the integrin avb6-specific 20-
mer peptide A20FMDV237 and EGF (see Figure 1a). A20FMDV2 was chosen as it was found to 
bind more selectively to αvβ6 integrins, an integrin family that is overexpressed in specific types 
of cancers: approximately one-third of carcinomas express αvβ6.38 EGF was employed as integrins 
work co-operatively with receptor tyrosine kinases39-41 to modulate cell behaviour: the reported 
activities of integrins and receptor tyrosine kinases on cancer cell behaviour and cancer 
development42 are likely to have been a product of functional co-regulation of these two receptor 
families.43 
The A20FMDV2 peptide was first conjugated to a ssDNA44 (see the Supporting Information (SI) 
and Figure S1). The conjugation was performed via maleimide-thiol strategy on the C-terminal 
cysteine modification of A20FMDV2 and the maleimide-modified ssDNA, and the conjugation 
products were validated and purified via size exclusion high-performance liquid chromatography 
(HPLC, see Figure S2a): the yield of conjugation was calculated to be of ca 63% (see the SI). The 
DNA-peptide conjugates were then assembled on the DNA nanostructures via in-solution 
hybridization with the complementary ssDNA “sticky-ends” present on the DNA origami by 
design (see Figure S1); the number and position of the peptides per DNA origami were controlled 
by the number and position of the sticky ends designed in the pristine DNA-origami. A 6-peptide 
modified DNA origami nanostructure was achieved at first and analysed by polyacrylamide gel 
electrophoresis (Figure S2b), confirming the presence of the peptide on the DNA-origami after 
hybridization. We designed the DNA origami to exhibit 60nm spacing between the A20FMDV2 
peptides, in line with the preferential spacing of ~60nm between integrin binding sites shown to 
be key for efficient cell spreading and viability10,24 as well as for the establishment of stable focal 
adhesions.11    
For the modification of the DNA-origami with EGF, biotin modified sticky ends were designed 
on the DNA nanostructures (see Figure S1) so to then bind streptavidin conjugated EGFs (see the 
SI and Figure 1a). In order to co-localize both the A20FMDV2 and EGF on the modified DNA 
origami system, the assembly of the EGF-streptavidin conjugate was performed on the previously 
constructed A20FMDV2 modified DNA nanostructures, employing biotinylated sticky ends which 
differ in position from the A20FMDV2 modified ones (see Figure 1a). The assembled 
nanostructures were further validated by Atomic Force Microscopy (AFM) imaging by casting 
diluted solutions on muscovite mica substrates (Figure 1b). The streptavidin-modified EGFs are 
clearly visible under AFM and were revealed to be around 5 nm in height, in agreement with their 
size when cast pristine on mica. Notably, the yield of EGF modification was found to be up to 
87%. 
 
Figure 1. (a) Schematic of modifying EGF and A20FMDV2 peptide on triangular DNA origami. 
(b) AFM images of EGF modified DNA origami. i) The EGF by itself scanned under AFM is 
shown. ii) The zoom-in AFM image of EGF modified origami. 
In order to organize on surfaces the A20FMDV2-	and EGF-modified DNA origami in array 
configurations, we covalently immobilized them on patterned arrays fabricated employing our 
recently developed FIB strategy.33,45 Highly uniform nanoarrays can be formed with a one-step 
lithographic process on metal-coated glass SiO2 surfaces; apertures matching the size of the DNA 
origami employed were patterned, and the exposed glass substrate was functionalized with 
carboxylic-terminating silane (see Figure S3). This allowed us to covalently bind on these 
apertures our DNA-origami pre-designed to exhibit amino-terminating ssDNA employed as 
anchoring moieties for surface immobilization (see Figure S3).  Figure 2a shows AFM images 
demonstrating the selective placement of ligand-modified DNA origami in the patterned 
nanoapertures, via the covalent immobilisation approach on the exposed SiO2 surface: a high yield 
of 82% ± 0.17 over arrays of 64 µm2 can be achieved for the one-to-one immobilisation of DNA 
origami per nanoaperture. 
The controlled nanoscale arrangement of the functional ligands (A20FMDV2 and/or EGF) on 
the DNA nanostructures, combined with the aforementioned patterning strategy, allowed us to 
fabricate arrays of multi-ligand functionalized DNA-origami. A spacing of 60nm between ligands 
was chosen as this was proven to be the ideal spacing between integrin binding sites for efficient 
cell spreading and viability.11,15,20 Additionally, a 300 nm spacing per nanoaperture, and hence per 
DNA origami, was chosen as the standard spacing for the nanoarrays in order to achieve a density 
of at least 87 ligands per µm2 (See Figure S4)46. The substrates were then employed as multivalent 
ECM-mimicking biochips for cell adhesion and spreading investigations: Figure 2b shows a 
schematic of the typical experimental set-up.  
In our studies we employed an isogenic pair of human melanoma cell lines (A375Ppuro and 
A375Pb6) that differed only in their expression of integrin avb6. Differences in the binding of the 
avb6-positive A375Pβ6 cells compared with the binding of the avb6-negative A375Ppuro cells 
can therefore be taken as an indication of the binding activity of the αvβ6 integrins. It should be 
noted, that although the isogenic pair was used as a model for αvβ6-dependent binding, both cell 
lines are able to respond to EGF.47-49 Thus, the biological responses of different receptor classes on 
cells binding to different ligand classes can be investigated; this can be achieved with single 
molecule control (one ligand per integrin/EGF) and nanoscale spatial resolution, by employing the 
multivalent platform developed here.  
All patterned substrates were blocked with 1% BSA prior to cell plating in order to reduce the 
nonspecific adhesion, and only expose the patterned ligands. Plain patterned substrates without 
any DNA immobilised on the surface were employed as blank control samples, while non-
modified origami immobilised on the substrates were used as another set of control samples (i.e. 
with origami that did not exhibit any ligands). Moreover, both types of cells were also plated on 
plain glass coverslips saturated with binding sites (see the experimental section), employed as 
positive control samples. The same numbers of cells were plated on each substrate and incubated 
for 1.5 hours. Careful PBS washing was carried out after cell incubation, and the substrates were 
then imaged under differential interference contrast microscopy (DIC).  
 
2 µm 
Figure 2. (a) Representative AFM image of the assembly of DNA origami in nanoarrays via 
covalent immobilisation in pre-patterned nanoapertures: the zoom-in AFM image shows one 
origami in the nanoaperture; (b) schematic of cell spreading studies on patterned functionalised 
DNA origami. 
Figure 3a-i shows DIC images of A375P cells (both A375Ppuro and A375Pb6 cells) on 
substrates nanopatterned with triangular DNA origami containing six A20FMDV2 peptides each 
(see the experimental section). The substrates engineered with the DNA origami containing the 
peptides induced a higher degree of A375Pβ6 cell spreading (up to 63 ± 5.3 %) compared to those 
on blank patterned and plain origami functionalised slides (approximately 1%): see Figure 3a-ii. 
Notably, on the peptide modified substrates, the A375Ppuro cells exhibited a lower spreading 
degree compared to A375Pβ6 cells, likely due to avb6 integrin expression only on the A375Pb6 
cells. Additionally, plain DNA origami nanostructures were revealed to promote no binding of 
either cell types (approximately 1%). These data indicate that cell spreading relied only on cell 
attachment to the A20FMDV2 peptides. 
Cell spreading studies were then performed employing DNA origami substrates modified with 
both A20FMDV2 peptides and EGF (both ligands arranged on each DNA-origami, that in turn 
were organized in arrays). Substrates modified with only A20FMDV2 peptides, and ones modified 
with only EGF, were also tested as control samples in order to reveal the independent binding 
properties of these two ligands: this comparison would highlight the cooperative nature of the two 
ligands. Because we employed an EGF-streptavidin-biotin conjugation approach to modify the 
DNA origami with EGF, streptavidin-only modified substrates were also used as controls to rule 
out any potential active role of streptavidin in cell binding. Moreover, plain patterned substrates 
without any DNA, and plain glass coverslips were employed as usual as blank controls and positive 
controls: the blank control did not present any cell-binding ligands, while the positive control was 
saturated with cell-binding ligands. A375Pb6 and A375Ppuro cells were plated onto all these 
substrates; cell spreading investigations were then performed via DIC (see Figures 3b-i), and the 
cell spreading numbers and areas (assessed via ImageJ), indicating the cell spreading level, were 
quantitatively analyzed as percentages compared to the positive control samples saturated with 
cell-binding ligands11,20 (Figure 3b-ii). 
On substrates modified with both ligands (with a density of 87 peptides/µm2 and 44 EGF 
molecules/µm2), the A375Pb6 cells showed a significantly higher percentage of spreading (77% 
±6.3, p<0.05) compared to spreading onto A20FMDV2 peptide-only substrates (57% ±4.7) and 
EGF-only substrates (35% ±5.1). Differently, the A375Ppuro exhibited only 6% ±1.2 spreading 
onto A20FMDV2 peptides-only substrate, but showed 42% ±4.9 spreading to the EGF-only 
origami, and 47% ±5.8 to the A20FMDV2/EGF-expressing origami.  These data suggest the 
enhanced spreading exhibited by A375Pb6 in the double ligand-coated origami is due to the 
expression of avb6. Additionally, Streptavidin modified substrates showed negligible cell 
spreading (3% for A375Ppuro cells and 4% for A375Pb6 cells), indicating that streptavidin does 
not affect cell binding. Notably, for A375Pb6 cells, there was a higher spreading cell behaviour 
(75% ±6.5, p<0.05) observed on substrates modified with both ligands, while for A375Ppuro cells 
the spreading in the presence of both ligands was found to be just below 50%.  
These results suggest that both A20FMDV2 peptides and EGF exhibit a positive effect on the 
establishment of spreading for A375Pb6 cells. While A20FMDV2-substrates showed selective 
binding of A375Pb6 but not of A375Ppuro cells, EGF was positive to both A375Pb6 and 
A375Ppuro cells: the cooperative effect of the A20FMDV2 and EGF ligands is highlighted by the 
promotion of cell spreading for both cell types. It is important to remark that a boost in cell 
spreading was observed especially for A375Pb6 cells: 77% for ß6 compared to 47% for 
A375Ppuro. This strongly suggest that both types of ligands need to be present for the 
establishment of a significant yield of spreading for A375Pb6 cell lines (Figure 3b-iii).  
 
Figure 3. (a) A375Ppuro (blue) and A375Pb6 (orange) cell spreading study on patterned DNA 
origami substrates with 300 nm spacing: i) DIC images of cell spreading on different substrates 
(positive control, blank, plain origami, and O+P (peptide assembled origami)) with 4× zoom-in 
insert images; ii) quantitative analysis of cell spreading on each substrate. The percentage of 
adherent cells compared to positive control and standard errors are shown. A promotion of 
A375Pb6 cells spreading was shown on the peptides modified origami substrate (63%) (#p < 0.05 
vs. positive control sample, and *p < 0.05 vs. O+P sample group). (b) A375Ppuro and A375Pb6 
cell spreading study on substrates modified with both A20FMDV2 peptide and EGF: i) DIC 
images of cells spreading on different substrates (positive control, blank, O+P (peptide assembled 
origami), O+EGF (EGF assembled origami), O+S (Streptavidin assembled origami), and 
O+EGF+P (both peptide and EGF assembled origami)) with 4× zoom-in insert images; ii) 
quantitative analysis of cell spreading on each substrate. The percentage of adherent cells 
compared to the positive control, and the standard errors are shown. iii) Zoom-in DIC images of 
A375Pb6 cell spreading on DNA origami substrates modified with both A20FMDV2 and EGF: a 
high level of spreading was shown. (#p < 0.05 vs. positive control sample, and *p < 0.05 vs. 
O+EGF+P sample group). 
In order to further investigate the cooperation between A20FMDV2 and EGF, we varied the 
ratio between the two ligands in each DNA origami and investigated the cell spreading of the 
A375P cell line. DNA nanostructures exhibiting different combinations were assembled by 
modifying specific staple strands at selected positions on the DNA origami: we employed ratios 
of peptide to EGF of 1:1, 1:3, 3:3, 3:6, 3:1 and 6:3. Both A375Ppuro and A375Pb6 cells were 
plated on the different multivalent nanoarray chips; their spreading was investigated via DIC 
imaging (Figure 4a). A quantitative analysis of the percentage of adhering cells and cell areas was 
calculated for each experiment: Figure 4b summarizes the results obtained.  
For all ratios, the spreading of A375Pb6 cells were shown to be above 50% when both EGF and 
A20FMDV2 were present on the DNA-origami nanoarray. Additionally, we observed a A375Pb6 
cell spreading efficiency above 60% when at least 3 A20FMDV2 (P) peptides were present per 
DNA-origami. In particular, we found this spreading efficiency to range between 66% ±6.0 and 
78% ±6.3, depending on the number of concomitant EGF (E) on the DNA-nanostructure. In this 
regard, the spreading increased with the higher number of EGF per DNA nanostructure: from 66% 
±6.0 (for a ratio P:E=3:1) to 71% ±5.7 (for P:E=3:3), and 78% ±6.3 (for P:E=3:6) (p<0.05). The 
best yield for ß6 cell spreading was therefore observed for the combination Peptide:EGF(P:E) with 
a ratio of 3:6, resulting in 78% spreading efficiency (see Figure 4b);  this result is also corroborated 
by the cell area analysis: see Figure 4b-ii.   
 
Figure 4. Study of the cooperation between the peptide and EGF as a function of their ratio from 
1:1 to 6:3. (a) A375Ppuro and A375Pb6 cell spreading study on patterned DNA origami substrates 
with different combination of A20FMDV2 peptide to EGF:  1:1, 1:3, 3:3, 3:6, 3:1 to 6:3: DIC 
images of cell spread on different substrates with 4× zoom-in insert images. Modified origami 
models and AFM characterisations are shown; (b) quantitative analysis of cell spreading on each 
substrate; i) the percent of adherent cells compared to positive control are shown with standard 
errors; the increase of EGF favours spreading of A375Pb6 cells, while the presence of at least 3 
peptides increases spreading above 65% (and up to 78%): the best ratio for cell spreading was 
found to be Peptide:EGF=3:6. (#p < 0.05 vs. positive control sample, and *p < 0.05 vs. between 
different sample groups); ii) the average cell area counting was analysed which corroborated to 
the spreading analysis (#p < 0.05 vs. between each same condition of A375Ppuro and A375Pb6 
cell, and *p < 0.05 vs. between different sample groups, assessed via ImageJ). 
 
CONCLUSIONS 
In this work, we presented a strategy for the fabrication of biomimetic nanoarrays that permit 
the investigation of multivalent ligand-receptor molecule interactions in cell spreading, with 
nanoscale spatial resolution and single-molecule control. The substrates were patterned using 
DNA origami organized in arrays and modified to exhibit cell-adhesion ligands spaced 60nm apart: 
A20FMDV2 peptides and EGF were the two ligands investigated here, because of their known 
roles in binding to the ligand receptors on human melanoma cell lines. We investigated the 
attachment and spreading of an isogenic pair of human melanoma cell lines (A375Ppuro and 
A375Pb6) that differed only in their expression of integrin αvβ6, an integrin family that is 
overexpressed in specific types of cancers: approximately one-third of carcinomas express αvβ6. 
The data show that both cell types bound equally well to EGF-labelled origami, whereas binding 
to A20FMDV2 was almost exclusively by A375Pb6 cells. We found that A20FMDV2 and EGF 
exhibit a positive cooperation in promoting the spreading of A375Pb6 cells. An increase in the 
spreading efficiency was observed with increasing number of ligands, in line with A20FMDV2’s 
selective binding to αvβ6 integrins, and its cooperation with EGF.39-41 Moreover, we  found that the 
presence of at least 3 peptides in the system, hence 3 integrins per cluster, favors maximum 
attachment, while the best ratio for cell spreading was found to be Peptide:EGF=3:6. To the best 
of our knowledge, the multivalent platform we have developed allowed for this cooperative effect 
to be demonstrated with single-molecule control and nanoscale spatial resolution. This 
methodology will allow us to dissect, in future studies, the stoichiometry of receptor interactions 
and the consequential signaling pathways that regulate both normal and cancer cell behavior, with 
molecular control. Additionally, the platform we presented here is of general applicability for the 
study, with nanoscale spatial control and single-molecule resolution, of different multivalent 
interactions governing biological processes,50 from the function of cell-surface receptors51 to ligand-
protein binding30 and pathogen inhibition.52  
 
METHODS 
Synthesis of DNA Origami: DNA origami is assembled by combining M13mp18 (5 nM) and 
staple strands (50 nM) in 50 µL TAE buffer with 12.5 mM Mg2+ (See DNA sequences in supporting 
information: Table S1 and S2). M13mp18 is a bacteria phage vector strand with 7249 bases long. 
An appropriate quantity of ions, such as magnesium here or sodium in the DNA hybridisation 
approach, are demanded to equilibrate the electrostatic repulsion between highly negatively 
charged DNAs molecules. An amount of 12.5 mM Mg2+ was chosen based on balancing the 
increase of the yield and reduction of the aggregation. The mixture solution is heated to 94℃ to 
completely dihybridise all of dsDNA. Temperature step controlled cooled down approach is 
carried out in a PCR machine. From 94℃ to 65℃, cooling rate is about at 0.3℃ per minute. A 
cooling rate of 0.1℃ per minute is employed from 65℃ to room temperature. The self-assembled 
DNA origami is purified with Millipore Amicon Ultra 100 kDa spin columns in a centrifuge at 
13000 rpm for 2 minutes, 3 times, to get rid of access staple strands. Residues in the spin column 
is adjusted to a concentration around 20 nM by regulating the volume to about 50 µL. A NanoDrop 
Spectrophotometer is used to detect the rough concentration of DNA origami products based on 
the constant of a molecular weight of 330 g/mol per base and an extinction coefficient = 33 mg/ml 
for A260 = 1. The actual result is normally close to the estimated numbers. 
AFM Characterisation of DNA Origami: AFM was used to image the DNA origami structures. 
DNA origami is cast on either silicon dioxide, glass or mica surfaces for imaging. The DNA 
origami solution is diluted by TAE buffer with 30 mM Mg2+ to around 1nM in order to get a good 
separation of the DNA nanostructures once immobilised on surface. Magnesium is required in the 
procedure as an ion charged bridge, immobilising DNA origami to the substrate surfaces. Mica 
samples were cleaved twice by solid scotch tape immediately prior casting. 5 µL of diluted DNA 
origami solution was directly deposited on freshly cleaned mica and left to adsorb on the surface 
for 2 min. Subsequently, the substrate was washed by distilled water to remove non-absorbed 
origami and then blown dry by compressed air. ScanAsyst-Air tips with 0.4 N/m spring constant 
were used to scan the sample by AFM under ScanAsyst™ Mode. A resolution of 512 pixels per 
line with 1 Hz scan rate was chosen for appropriate imaging of the DNA nanostructure.  
Modifications of DNA Origami: Peptide A20FMDV2 was assemble on DNA origami using 
the Maleimide-Thiol linkage on ssDNA complimentary to sticky-ends. The numbers of peptides 
on a single origami depends on how many complementary sticky-ends that origami has. Up to six 
positions were chosen in this study (namely at A32, B32 C32, A37, B37, and C37 of a triangular 
DNA origami, see SI). Commercially available protected maleimide modified ssDNA need to be 
deprotected before conjugation. 50 nmoles of the protected maleimide modified ssDNA was freeze 
dried at first. Deprotection and conjugation will inefficient in the presence of water. Freeze dried 
samples were washed adding 2 mL of anhydrous acetonitrile, and the solvent was evaporated by a 
rotary evaporator. 2 mL of anhydrous toluene was added to the vial, mixed and then evaporated. 
The rinsing procedure was repeated for 3 times. In the third time, toluene was kept in vial and 
incubated at 90℃ for 4 hours to deprotect the maleimide-modifier. After incubation, toluene was 
evaporated. The vial containing the deprotected maleimide modified ssDNA was immediately 
mixed with the reduced peptide. The thiol group on the cysteine of the peptide needed to be reduced 
from the oxide form right before conjugation. The conjugation reaction occurs after the mixing. 
The mixture was put on a shaker for 1 hour to complete the conjugation. Peptide-ssDNA 
conjugation was validated and purified by reversed phase HPLC. Purified products were freeze 
dried and resuspended in TAE buffer. Peptide-ssDNA conjugation was mixed with staple strands 
and M13mp18, and standard DNA origami synthesis was carried out. A20FMDV2 is a linear 
peptide with 21 amino acid. Heating up to 94℃ will not affect the structure and function of this 
peptide. Epidermal growth factor (EGF) was modified on DNA origami via streptavidin-biotin 
conjugation. The EGF was biotinylated and assembled with streptavidin which is commercially 
available. Streptavidin modified EGF was attached on origami structure via incubating with DNA 
origami solution which have biotinylated sticky ends. AFM characterisation was carried out to 
confirm the EGF modification. 
DNA Origami Patterning: DNA origami was patterned on FIB nanofabricated coverslip 
substrate. DNA origami was first diluted 20 times in Tris buffer (5 mM; pH 8.2) with 30mM Mg2+. 
60 μL of the DNA origami solution was cast on the substrate and placed in a 6-wells plate with 
moist Kimwipe. The sample was incubated for 90 minutes on a shaker. The sample was then 
washed with Tris buffer (5 mM; pH 8.2) with 30 mM Mg2+ (60 μL × 8). A 0.01% solution of 
carboxyethylsilane in the same Tris buffer was washed in with (60 μL × 8), and the sample was 
incubated for 2 minutes on a shaker. The buffer was then exchanged for MOPS buffer (10 mM; 
pH 8.1) with 30 mM Mg2+ (60 μL × 8). An equal volume of EDC (1-Ethyl-3-(3-
dimethylaminopropyl) carbodiimide; 50 mM) and NHS (N- hydroxysulfosuccinimide; 100 mM) 
in the MOPS buffer was added to the sample’s volume and the sample was incubated for 10 
minutes on a shaker. The sample was washed with the MOPS buffer, then rinsed with DPBS with 
125 mM NaCl to remove any uncovalently bound structures, and subsequently rinsed with water. 
The samples were checked under AFM.  
Cell Spreading Study: Cells were grown at 37°C and 8% (v/v) carbon dioxide/air condition in 
a humidified incubator. Cells were maintained as adherent monolayers on tissue culture plastic. 
Growth medium contained of DMEM accompanied with 10% FBS. Cells were sub-cultured 
approximately every three days. After incubation with 0.25% (w/v) trypsin/EDTA solution, 
adhered cells were removed from culture plastic and neutralised by adding three folds of growth 
medium. Cells were then suspension to fresh tissue culture flasks with fresh growth medium. Cells 
were removed from tissue culture plastic by trypsin, and neutralised, pelleted and resuspended as 
described before. The cell concentrations were counted using cytometer for both Puro and ß6 cell 
lines. Same numbers of cells for both cell lines were applied on different pattern modified substrate 
in 24 wells plate. The substrates were blocked with 1% BSA before cells plating. 2 mL of growth 
medium were added to each well and then incubated for 1.5 hours. The substrates were carefully 
washed by PBS for 2 times to remove non-adhered cells. The patterned area with cells were imaged 
using differential interference contrast microscopy (DIC) to observe the cell behaviours. ImageJ 
was used for the cell numbers counting and average cell area analysis. The cell images were first 
threshold and the outline of cells were drawn manually. The entire cell areas were then calculated 
via the software and divided by the cell numbers.   
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